|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-1-29
|
|
pubmed:abstractText |
The incidence of type 2 diabetes mellitus (DM) is rapidly increasing worldwide. Results from large-scale studies show that tight blood glucose (BG) control improves the outcome of patients with type 2 DM.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biphasic Insulins,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Fructosamine,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Isophane,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin Aspart,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/insulin aspart, insulin aspart...,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3109-23
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14749149-Adult,
pubmed-meshheading:14749149-Aged,
pubmed-meshheading:14749149-Biphasic Insulins,
pubmed-meshheading:14749149-Blood Glucose,
pubmed-meshheading:14749149-Diabetes Mellitus, Type 2,
pubmed-meshheading:14749149-Drug Therapy, Combination,
pubmed-meshheading:14749149-Female,
pubmed-meshheading:14749149-Fructosamine,
pubmed-meshheading:14749149-Glyburide,
pubmed-meshheading:14749149-Hemoglobin A, Glycosylated,
pubmed-meshheading:14749149-Humans,
pubmed-meshheading:14749149-Hypoglycemic Agents,
pubmed-meshheading:14749149-Insulin,
pubmed-meshheading:14749149-Insulin, Isophane,
pubmed-meshheading:14749149-Insulin Aspart,
pubmed-meshheading:14749149-Male,
pubmed-meshheading:14749149-Middle Aged,
pubmed-meshheading:14749149-Thiazolidinediones,
pubmed-meshheading:14749149-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.
|
|
pubmed:affiliation |
Hadassah Ein Karem Medical Center, Jerusalem, Israel. ntv502@netvision.net.il
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
